Public Company News

DL E&C Marks First Entry into Canadian Blue Ammonia Market

* DL E&C Secures Canada Blue Ammonia Deal; CARBONCO Licenses CCUS Technology * Producing Over 1 Million Tons of Eco-Friendly Fertilizer Using Blue Ammonia and Captured CO₂ SEOUL, South Korea, Dec. 10, 2024 /PRNewswire/ -- DL Engineering & Construction (DL E&C), one ofSouth Korea's top five con...

2024-12-10 22:00 2740

Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released t...

2024-12-10 21:26 3023

Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care

– Collaboration combines Terumo's ePRISM™ precision medicine software platform withMedis' QFR® technology – SOMERSET, N.J., Dec. 10, 2024 /PRNewswire/ -- Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a leading cardiac imaging software...

2024-12-10 21:00 2401

Recurrent Energy Signs 300 MW Power Purchase Agreement with Major U.S. Tech Company in Spain

KITCHENER, ON, Dec. 10, 2024 /PRNewswire/ -- Recurrent Energy , a subsidiary of Canadian Solar Inc.  ("Canadian Solar") (NASDAQ: CSIQ) and a global developer, owner, and operator of solar and energy storage assets, announced today t...

2024-12-10 20:00 2713

SurplusGLOBAL to Participate in SEMICON JAPAN 2024, Showcasing AI-Based 'SemiMarket' and Legacy Equipment Solutions

SEOUL, South Korea, Dec. 10, 2024 /PRNewswire/ -- SurplusGLOBAL will participate in SEMICONJAPAN 2024, scheduled to take place from December 11 to 13 at Tokyo Big Sight,Japan. With 1,182 companies from around the world set to join the exhibition, SurplusGLOBAL will be showcasing its legacy semico...

2024-12-10 20:00 2671

ChipMOS REPORTS 2.8% MoM INCREASE IN NOVEMBER 2024 REVENUE, DOWN 2.1% YoY

HSINCHU, Dec. 10, 2024 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150 and Nasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"),...

2024-12-10 19:00 2575

Youdao 2024 Annual General Meeting of Shareholders

BEIJING, Dec. 10, 2024 /PRNewswire/ -- As announced on November 14, 2024, the Company is going to hold its annual general meeting of shareholders ("AGM") at itsBeijing offices on December 12, 2024 at 3:00 p.m. – 5:00 p.m. (Beijing Time). To watch the live broadcasting of the AGM, please click the...

2024-12-10 16:30 2575

Jinxin Technology Holding Company Announces Closing of US$5 Million Initial Public Offering

SHANGHAI, China, Dec. 9, 2024 /PRNewswire/ -- Jinxin Technology Holding Company (the "Company") (Nasdaq: NAMI), an innovative digital content service provider inChina, today announced the closing of its initial public offering (the "Offering") of 1,250,000 American Depositary Shares ("ADSs") at a...

2024-12-10 12:00 2803

Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW

Lunit INSIGHT MMG integrated into the clinical workflow of Australia's BreastScreen New South Wales to assist in reading approximately 31,000 mammography exams annually SEOUL, South Korea, Dec. 9, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer d...

2024-12-09 22:00 3147

Taoping Signs Non-binding Letter of Intent to Acquire Yunti; Transformational Acquisition Would Substantially Improve Taoping's Annual Revenue, Expand its Addressable Market, and Leverage its Current Portfolio

SHENZHEN, China, Dec. 9, 2024 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, new media and artificial intelligence (AI) solutions, today announced that it has signed a non-binding letter of intent to acquire 100% o...

2024-12-09 21:30 3646

Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial

* Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 * Appoints US-based Chief Commercial Officer, Andrew Udell * Xanamem's unique ability to control brain cortisol draws widespread coverage in the Australian media. SYDNEY, Dec. 9, 2024 /PRNewswire/ -- A...

2024-12-09 21:00 3139

Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate

BEIJING, Dec. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that the National Medical Products Administration of...

2024-12-09 20:30 3031

Noah Showcases Global Expansion and Investment Product Leadership at 2024 Corporate Open Day

* Accelerating global expansion into emerging markets with new brands * Global investment allocation strategies and expanded product offerings drive long-term value for clients * Expanding comprehensive service matrix to address evolving client needs globally SHANGHAI, Dec. 9, 2024 /PRNewswi...

2024-12-09 19:00 3287

Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-cell Non-Hodgkin Lymphoma at the 2024 ASH Annual Meeting

DZD8586 demonstrated encouraging anti-tumor activity with manageable safety and favorable pharmacokinetic (PK) characteristics in patients with B-NHL SHANGHAI, Dec. 9, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment o...

2024-12-09 18:00 2464

iQIYI Introduces 'Extra Large Font' Function to Enhance Accessibility for Senior Users

BEIJING, Dec. 9, 2024 /PRNewswire/ -- iQIYI, China's leading online entertainment platform, recently launched a new 'Extra Large Font' function on its app, offering a comprehensive suite of accessibility features tailored for senior users and the visual requirements of a broader audience. With ju...

2024-12-09 17:05 3134

Acer Announces November Revenues at NT$22.75 Billion, Up 20.9% Month-on-month and 13.1% Year-on-year

TAIPEI, Dec. 9, 2024 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for November atNT$22.75 billion with 20.9% growth month-on-month and 13.1% growth year-on-year (YoY). Consolidated revenues for year-to-November revenues reachedNT$240.16 billion with 10.4% growth YoY....

2024-12-09 16:44 2363

Hello Group Inc. Announces Unaudited Financial Results for the Third Quarter of 2024

BEIJING, Dec. 9, 2024 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading player in mainlandChina's online social networking space, today announced its unaudited financial results for the third quarter of 2024.   Third Quarter of 2024 Highlights * Net r...

2024-12-09 16:16 2834

2024 ASH Oral Presentation----Abbisko presents promising preliminary phase 2 study results of pimicotinib in the treatment of Chronic Graft-versus-Host Disease (cGvHD) at the 66th ASH Annual Meeting

SHANGHAI, Dec. 8, 2024 /PRNewswire/ -- December 8, 2024, Abbisko Therapeutics (HKEX: 02256) announced the presentation of preliminary Phase 2 study results for pimicotinib (ABSK021) in patients with chronic Graft-versus-Host Disease (cGvHD) who have either progressed or not responded to one or mo...

2024-12-09 10:40 2589

Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH

BEIJING, SHANGHAI and BOSTON, Dec. 8, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company dedicated to developing therapies toward  undruggable targets, today presented preliminary Phase I data of BET inhibitor JAB-8263 to treat myelofibrosis (MF) at the 2024 ASH (Ame...

2024-12-09 08:42 2308

Caliway Biopharmaceuticals Included in FTSE TWSE Taiwan Eight Industries and Mid-Cap 100 Indices

NEW TAIPEI CITY, Dec. 6, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals Co., Ltd. (TWSE-6919) is proud to announce its inclusion in the FTSE TWSE Taiwan Mid-Cap 100 Index and the FTSE TWSE Taiwan Eight Industries Index, two prestigious benchmarks jointly compiled by FTSE Russell and the Taiwan S...

2024-12-07 08:57 4617
1 ... 220221222223224225226 ... 763

Week's Top Stories